Improving the reporting of clinical case series

American Journal of Ophthalmology

Volumn 139, Issue 5, 2005, Pages 900-905

  Jabs, Douglas A ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT;

ANALYTICAL ERROR; ARTIFACT REDUCTION; BEHCET DISEASE; DATA ANALYSIS; FOLLOW UP; HUMAN; LEUKOPENIA; METHODOLOGY; PRIORITY JOURNAL; PROBLEM SOLVING; RETINITIS; REVIEW; STATISTICAL ANALYSIS; UVEITIS; VISUAL ACUITY; VISUAL THRESHOLD;

EID: 18144377973     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2004.12.009     Document Type: Editorial

References (19)

1. Armitage P, Berry G. Statistical methods in medical research, 2nd ed., Oxford: Blackwell Scientific.
2. D.A. Jabs, C. Enger, J.G. Bartlett Cytomegalovirus retinitis and acquired immunodeficiency syndrome Arch Ophthalmol 107 1989 75 80
3. D.F. Martin, D.J. Parks, S.D. Mellow Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant A randomized controlled clinical trial Arch Ophthalmol 112 1994 1531 1539
4. H.L. Cantrill, K. Henry, N.H. Melroe Treatment of cytomegalovirus retinitis with intravitreal ganciclovir Long-term results Ophthalmology 96 1989 367 374
5. M.H. Heinemann Long-term intravitreal ganciclovir therapy for cytomegalovirus retinopathy Arch Ophthalmol 107 1989 1767 1772
6. I. Cochereau-Massin, P. Lehoang, M. Lautier-Frau Efficacy and tolerance of intravitreal ganciclovir in cytomegalovirus retinitis in acquired immune deficiency syndrome Ophthalmology 98 1991 1348 1353
7. A. Hillis, M. Maguire, B.S. Hawkins, M.M. Newhouse The Markov process as a general method for nonparametric analysis of right-censored medical data J Chron Dis 39 1986 595 604
8. B.A. Mudun, A. Ergen, S.U. Ipcioglu Short-term chlorambucil for refractory uveitis in Behçet's disease Ocul Immunol Inflamm 9 2001 219 229
9. J.T. Holbrook, M.D. Davis, Hubbard for the Studies of Ocular Complications of AIDS Research Group Risk factors for advancement of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome Arch Ophthalmol 118 2000 1196 1204
10. D.A. Jabs, M.L. Van Natta, J.E. Thorne for the Studies of Ocular Complications of AIDS Research Group Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 1. Retinitis progression Ophthalmology 111 2004 2224 2231
11. D. Monnet, M. Breban, C. Hurdy, M. Dougados, A.P. Brezin Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis a study of 175 cases Ophthalmology 11 2004 802 809
12. B.J. Mondino, S.I. Brown Ocular cicatricial pemphigoid Ophthalmology 88 1981 95 100
13. D.A. DiLoreto Jr, N.M. Bressler, S.B. Bressler, A.P. Schachat Use of best and final visual acuity outcomes in ophthalmological research Arch Ophthalmol 121 2003 1586 1590
14. D.A. Jabs Ocular manifestations of HIV infection Trans Am Ophthalmol Soc 93 1995 623 683
15. F.L. Ferris III, A. Kassoff, G.H. Bresnick, I. Bailey New visual acuity charts for clinical research Am J Ophthalmol 94 1982 91 96
16. K.V. Liang, S.L. Zuger Longitudinal data analysis using generalized linear models Biometrika 73 1986 13 22
17. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 4 Visual outcomes Ophthalmology 101 1994 1250 1261
18. C.S. Foster, F. Tufail, N.K. Waheed Efficacy of etanercept in preventing relapse of uveitis controlled by methotrexate Arch Ophthalmol 121 2003 437 440
19. D. Moher, K.F. Schultz, D. Altman CONSORT Group The CONSORT Statement Revised recommendations for improving the quality of reports of parallel-group randomized trials JAMA 285 1987 1987 1991